ObsEva is a biopharmaceutical company that develops and commercializes novel therapeutics for woman’s reproductive health and pregnancy.Read more
Evofem is a top competitor of ObsEva. Evofem was founded in 2009, and is headquartered in San Diego, California. Like ObsEva, Evofem also competes in the Biotechnology field. Evofem generates $7.4M more revenue vs. ObsEva.
Myovant Sciences is seen as one of ObsEva's top competitors. Myovant Sciences is headquartered in Brisbane, California, and was founded in 2016. Like ObsEva, Myovant Sciences also operates in the Biotechnology field. Myovant Sciences generates 966,188% the revenue of ObsEva.
September 21, 2021
$ < 1M
ObsEva's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 4.2B. Over the last two quarters, ObsEva's revenue has grown by 100%. Specifically, in Q4 2020's revenue was $ < 1M; in Q3 2020, it was $ < 1M.
No recent acquisitions found related to ObsEva
Since ObsEva was founded in 2012, it has participated in 6 rounds of funding. In total ObsEva has raised $326.2M. ObsEva's last funding round was on Aug 2019 for a total of $75.0M
No recent investments found related to ObsEva